Biomerica, Inc. (BMRA)
1.68
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
1.71
+0.03
(+1.79%)
After-Hours: 20:00
Biomerica Enterprise Value : 7.319M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 7.319M |
| October 22, 2026 | 7.319M |
| October 21, 2026 | 7.457M |
| October 20, 2026 | 7.497M |
| October 19, 2026 | 7.687M |
| October 16, 2026 | 8.101M |
| October 15, 2026 | 8.216M |
| October 14, 2026 | 7.871M |
| October 13, 2026 | 8.101M |
| October 12, 2026 | 8.032M |
| October 09, 2026 | 8.033M |
| October 08, 2026 | 8.285M |
| October 07, 2026 | 8.377M |
| October 06, 2026 | 9.435M |
| October 05, 2026 | 9.021M |
| October 02, 2026 | 9.444M |
| October 01, 2026 | 9.873M |
| September 30, 2026 | 9.987M |
| September 29, 2026 | 10.17M |
| September 28, 2026 | 10.58M |
| September 25, 2026 | 10.26M |
| September 24, 2026 | 10.91M |
| September 23, 2026 | 11.57M |
| September 22, 2026 | 12.38M |
| September 21, 2026 | 11.55M |
| Date | Value |
|---|---|
| September 18, 2026 | 11.14M |
| September 17, 2026 | 10.45M |
| September 16, 2026 | 10.49M |
| September 15, 2026 | 10.17M |
| September 14, 2026 | 10.45M |
| September 11, 2026 | 9.895M |
| September 10, 2026 | 9.849M |
| September 09, 2026 | 10.01M |
| September 08, 2026 | 10.35M |
| September 04, 2026 | 10.22M |
| September 03, 2026 | 9.803M |
| September 02, 2026 | 9.711M |
| September 01, 2026 | 9.205M |
| August 31, 2026 | 9.205M |
| August 28, 2026 | 7.913M |
| August 27, 2026 | 7.785M |
| August 26, 2026 | 6.475M |
| August 25, 2026 | 6.731M |
| August 24, 2026 | 6.443M |
| August 21, 2026 | 6.219M |
| August 20, 2026 | 6.140M |
| August 19, 2026 | 5.932M |
| August 18, 2026 | 6.188M |
| August 17, 2026 | 6.060M |
| August 14, 2026 | 6.124M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.10B |
| Align Technology, Inc. | 10.03B |
| AngioDynamics, Inc. | 501.34M |
| Accuray, Inc. | 162.02M |
| Alphatec Holdings, Inc. | 2.205B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.232M |
| Revenue (Quarterly) | 1.265M |
| Total Expenses (Quarterly) | 2.497M |
| EPS Diluted (Quarterly) | -0.3738 |
| Gross Profit Margin (Quarterly) | 8.14% |
| Profit Margin (Quarterly) | -97.39% |
| Earnings Yield | -97.40% |
| Normalized Earnings Yield | -101.95 |